RhumbLine Advisers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.72M Buy
496,563
+5,142
+1% +$61.5K 0.01% 1315
2026
Q1
$2.94M Buy
491,421
+20,859
+4% +$157K ﹤0.01% 1656
2025
Q4
$3.37M Buy
470,562
+1,812
+0.4% +$14.3K ﹤0.01% 1602
2025
Q3
$5.01M Sell
468,750
-10,271
-2% -$101K ﹤0.01% 1440
2025
Q2
$4.64M Sell
479,021
-25,984
-5% -$268K ﹤0.01% 1447
2025
Q1
$7.52M Sell
505,005
-6,101
-1% -$93.8K 0.01% 1152
2024
Q4
$7.63M Sell
511,106
-14,051
-3% -$229K 0.01% 1201
2024
Q3
$10M Sell
525,157
-2,672
-0.5% -$55.4K 0.01% 1049
2024
Q2
$10.9M Sell
527,829
-16,312
-3% -$324K 0.01% 983
2024
Q1
$10.2M Sell
544,141
-33,296
-6% -$571K 0.01% 1032
2023
Q4
$8.33M Buy
577,437
+128,001
+28% +$1.74M 0.01% 1148
2023
Q3
$7.8M Sell
449,436
-6,384
-1% -$133K 0.01% 1111
2023
Q2
$9.49M Sell
455,820
-5,560
-1% -$121K 0.01% 1036
2023
Q1
$10.9M Buy
461,380
+14,110
+3% +$379K 0.01% 927
2022
Q4
$12.5M Buy
447,270
+16,590
+4% +$424K 0.02% 824
2022
Q3
$10.1M Buy
430,680
+17,640
+4% +$533K 0.02% 883
2022
Q2
$13.9M Buy
413,040
+43,573
+12% +$1.53M 0.02% 728
2022
Q1
$12.9M Sell
369,467
-20,580
-5% -$704K 0.02% 831
2021
Q4
$11.9M Buy
390,047
+8,812
+2% +$287K 0.01% 894
2021
Q3
$12.5M Sell
381,235
-3,684
-1% -$118K 0.02% 839
2021
Q2
$11.6M Buy
+384,919
New +$12.7M 0.02% 911

Other funds holding OGN

RhumbLine Advisers's OGN Position: Q2 2026 in Review

RhumbLine Advisers increased its Organon & Co (OGN) stake by 1% in Q2 2026, buying an estimated $61.5K and bringing the position to 496,563 shares worth $6.72M. The position accounts for 0.01% of the portfolio, ranked #1315.

RhumbLine Advisers first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $13.9M in Q2 2022. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • RhumbLine Advisers held 496,563 shares of Organon & Co worth $6.72M as of Q2 2026.
  • RhumbLine Advisers bought 5,142 Organon & Co shares in Q2 2026, an estimated $61.5K.
  • Organon & Co made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1315 holding.
  • RhumbLine Advisers first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • RhumbLine Advisers's Organon & Co position peaked at $13.9M in Q2 2022.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.